Gladstone welcomes inquiries from journalists. Our media relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Coronavirus
Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the public health impacts.
Contact
For media inquiries or interview requests, email media-relations@gladstone.org
Kelly Quigley
Director, Science Communications & Media Relations
Direct line: 858-997-9462
Email
Anna-Marie Rooney
Vice President, Communications
Email
News Releases
61 - 75 of 183 Results
Mutant Stem Cells Defy Rules of Development
Mutant Stem Cells Defy Rules of Development
Removing one gene from developing heart cells suddenly makes them turn into brain cell precursors, making researchers rethink cellular identity
News Release Research (Publication) Cardiovascular Disease Bruneau Lab Stem Cells/iPSCs HotaKaterina Akassoglou Elected Lifetime AAAS Fellow
Katerina Akassoglou Elected Lifetime AAAS Fellow
Gladstone investigator receives distinct honor within the scientific community
Awards News Release Neurological Disease Akassoglou LabResearchers Pioneer New Method to Edit Genes in Human Cells
Researchers Pioneer New Method to Edit Genes in Human Cells
Retrons could revolutionize gene editing for research and medicine
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene EditingStrains—not Species—of Gut Microbes Hold Key to Health and Disease
Strains—not Species—of Gut Microbes Hold Key to Health and Disease
Two new studies underscore the importance of looking at bacterial strains when analyzing the human gut microbiome
News Release Research (Publication) Data Science and Biotechnology Pollard Lab Big Data MicrobiomeA New Class of Antiviral Therapy Could Treat COVID-19
A New Class of Antiviral Therapy Could Treat COVID-19
Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab ChaturvediNew Tech Assigns More Accurate “Time of Death” to Cells
New Tech Assigns More Accurate “Time of Death” to Cells
The method lets researchers more easily study factors that can lead to cell death, in conditions including neurodegenerative diseases
News Release Research (Publication) Center for Systems and TherapeuticsKaterina Akassoglou Elected to National Academy of Inventors
Katerina Akassoglou Elected to National Academy of Inventors
Gladstone scientist receives highest distinction for academic inventors
Awards News Release Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Akassoglou LabIt Takes Guts to Make a Heart
It Takes Guts to Make a Heart
Gladstone scientists create novel organoids that open new doors for understanding crosstalk between tissues during human development
News Release Research (Publication) Cardiovascular Disease McDevitt Lab OrganoidsInventing New Ways to View Biology
Inventing New Ways to View Biology
Vijay Ramani, who develops novel tools to study single molecules, joins Gladstone Institutes
Institutional News News Release Profile Data Science and Biotechnology Ramani LabAlzheimer’s Disease May Cause Vicious Circle between Brain Network and Immune Cell Dysfunctions
Alzheimer’s Disease May Cause Vicious Circle between Brain Network and Immune Cell Dysfunctions
Gladstone scientists identified treatments to block subtle epileptic activity and chronic brain inflammation in a mouse model of Alzheimer’s disease
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke LabMaintaining Balance in the Brain
Maintaining Balance in the Brain
Gladstone scientists help explain how reducing the protein tau can prevent abnormal brain activity associated with Alzheimer’s disease, autism, and epilepsy
News Release Research (Publication) Alzheimer’s Disease Epilepsy Neurological Disease Mucke LabGladstone Neuroscience Researcher Elected to the National Academy of Medicine
Gladstone Neuroscience Researcher Elected to the National Academy of Medicine
Lennart Mucke is recognized for his pioneering discoveries in research on Alzheimer’s disease and related disorders
Awards News Release Neurological Disease Mucke LabImmune Response to COVID-19 Vaccine Different with Prior Infection
Immune Response to COVID-19 Vaccine Different with Prior Infection
Gladstone researchers studied how T cells respond to COVID-19 vaccines over the weeks following immunization
News Release Research (Publication) COVID-19 Virology Roan LabCan an Already Approved Drug Treat Alzheimer’s Disease?
Can an Already Approved Drug Treat Alzheimer’s Disease?
Researchers pinpoint an existing drug that reverses signs of Alzheimer’s disease in mice and may prevent the disease in humans
News Release Research (Publication) Alzheimer’s Disease Huang LabGladstone Investigators Win NIH Director’s Awards
Gladstone Investigators Win NIH Director’s Awards
The awards will support high-risk, high-reward research into a fundamentally new type of antiviral and a molecular strategy to fight cancer
Grants News Release COVID-19 Ramani Lab Weinberger Lab